Eyed Pharma SA
29.0 FTEEyed Pharma reported revenue of €10.5m for the 2025 financial year (annual accounts filed with the NBB on 22 Sep 2026), with 29 full-time equivalents.
The score of Eyed Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +7 % Total assets +87 % Headcount (avg FTE) -28 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Eyed Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €10.5m | ||||
| Net result | −€6.92m | ||||
| Equity | €17.4m | ||||
| Cash | €1.30m | ||||
| EBITDA | −€2.70m | ||||
| Total assets | €50.6m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Sep 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 23 Aug 2022
Eyed Pharma's financial analysis
- Solvency34.3%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eyed Pharma
Eyed Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0508.599.605
- VAT number
- BE0508599605
- Peppol
- Registered · 0208:0508599605 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Dec 2012
- Registered office
- 4000 Liège
- Size
- Small · 29.0 FTE
- Latest accounts
- 2025 · filed on 22 Sep 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Eyed Pharma (SA) has been based in Liège since 2012, active in: research and experimental development on biotechnology. For 2025, it reports revenue of €10.5m, a net loss of €6.92m and equity of €17.4m. With 29.0 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 34.3%, below the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Eyed Pharma
Companies in the same business, of comparable size and area, outside its group.
- Besins Healthcare Pharmtech Manufacture of pharmaceutical preparations Seraing · balance sheet €23.7m
- Odyssea Pharma Manufacture of pharmaceutical preparations Grâce-Hollogne · balance sheet €91.0m
- Baxter Manufacture of pharmaceutical preparations Lessines · balance sheet €160.0m
- Omega Pharma Innovation & Development Research and experimental development on natural sciences and engineering Ghent · balance sheet €246.6m
- Amgen Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €45.6m
- Telix Innovations Manufacture of basic pharmaceutical products Herstal · balance sheet €473.4m
- Laboratoires S.M.B. Manufacture of pharmaceutical preparations Molenbeek-Saint-Jean · balance sheet €261.5m
- Eli Lilly European Clinical Trial Services Manufacture of medical and dental instruments and supplies Mont-Saint-Guibert · balance sheet €57.4m
Frequently asked questions about Eyed Pharma
What is the revenue of Eyed Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of Eyed Pharma amounts to 10,494,903 €.
What is the VAT number of Eyed Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0508599605 for Eyed Pharma, if the company is VAT-registered. Its company number (CBE) is 0508.599.605.
Where is the registered office of Eyed Pharma?
According to the CBE register, the registered office of Eyed Pharma is in 4000 Liège.
What is the equity of Eyed Pharma?
At the close of the 2025 financial year, the equity of Eyed Pharma amounts to 17,370,564 €, a solvency of 34.3% of total assets.
How many people work at Eyed Pharma?
29.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Eyed Pharma?
The register lists 14 active mandates at Eyed Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Eyed Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →